Bellevue Group AG Boosts Stock Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bellevue Group AG boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,091,000 shares of the company’s stock after purchasing an additional 369,500 shares during the period. Revolution Medicines […]

Related Keywords

Jack Anders ,Raymond James ,Jeff Cislini ,Piper Sandler ,Bellevue Group ,Nasdaq ,Revolution Medicines Inc ,Exchange Commission ,Securities Exchange Commission ,Bain Capital Life Sciences Investors ,Rafferty Asset Management ,Investment Management ,Revolution Medicines ,Free Report ,Fire Capital ,Point Capital ,Capital Life Sciences Investors ,Asset Management ,Medicines Stock Down ,Get Free Report ,General Counsel Jeff Cislini ,Visit Holdingschannel ,Revolution Medicines Daily ,